Speaking at the Asian Strategy and Leadership Institute (ASLI) HealthCare Forum 2015 at the Palace of the Golden Horses on the 12th of March 2015, Minister of Health, YB Datuk Seri Dr. S Subramanian, quoted the 2011 National Health and Morbidity study as to showing increasingly alarming data on Malaysian public health.
The study found that 70% of deaths in hospitals, both private and public, are due to non-communicable diseases, of which 30% of the afflicted were below 55 years old age. Non-communicable diseases are diseases like diabetes, hypertension, cholesterol and obesity.
For illustration purposes, assume that one person has only one type of affliction (as is not the case – as people with obesity tend to also suffer from hypertension, etc), more than half of Malaysia’s 30 million population would have some form of disease, as the 17.1 million statistic is made up of 2.6 million diabetics, 5.8 million of hypertension sufferers, 6.2 million of those with high cholesterol and 2.5 million obese people, making us also the most obese society in South East Asia, and as Datuk Seri Dr. Subramaniam says, it’s “definitely not something to be proud of”.
The conference, themed ‘Malaysian Healthcare: Trends, Opportunities & Challenges’ saw participation from 150 key role players from pharmaceuticals, government officials, medical associations and industry leaders which sought to answer the challenges raised by the minister, as well as those presented by its six moderators.